- Home
- Clinical Trials
Chlamydia Study Sydney DH 00
Chlamydia Study
Darlinghurst Sydney
Did you know that more than 80% of people with chlamydia do not show any symptoms and can unknowingly spread the infection?
Did you know that chlamydia infection can lead to infertility and an increased risk of HIV?
Join a clinical research study and help researchers find a potential vaccine that may protect the sexual health of your community.
Participants will be reimbursed.
Description
What to expect
Study details
Ages
18 to 29 years old
Duration
18 months with up to 14 clinic visits
Compensation
Eligible participants will be reimbursed
Eligibility Criteria
You may qualify for this study if you:
- Are aged 18 to 29 years old AND
- Are currently sexually active and one of the following circumstances apply to you
- You have had a new sexual partner in the last 6 months
- You are not consistent with condom use
- Your sexual partner has had a previous or current STI
- You currently engage in sexual activities with more than one partner
Locations
Description
Chlamydia is the most common bacterial sexually transmitted infection (STI) worldwide. In most cases (more than 80%), people do not show symptoms and can unknowingly spread the infection. In women, untreated chlamydia can lead to serious health problems such as pelvic inflammatory disease (a major cause of infertility), ectopic pregnancy, and chronic pelvic pain. It also increases the risk of HIV infection, while in men it may cause urethritis and epididymitis.
Because current prevention methods (like using condoms and sexual education) have limited effectiveness in real-life settings, there is a need for a vaccine that can protect people against chlamydia infection.
What to expect
Momentum Clinical Research is evaluating a potential vaccine that is designed to prevent both chlamydia primary infections and reinfections. The vaccine works by using messenger RNA (mRNA) to instruct the body’s cells to produce specific proteins that stimulate an immune response that canprevent a chlamydia infection.
The aim of this study is to measure the safety, efficacy, and immune response of 3 different dosage levels and a placebo of the study vaccine. During the study, participants will receive ongoing health monitoring and
assessments.
By participating in this study, you could help contribute to the development of a vaccine that may protect the sexual health of those in your community and future generations.
Register your interest now to find out if you are eligible to participate in this clinical research study.
Apply now
Fill out your details, and our team will be in touch to discuss your potential involvement in this study and answer any questions you may have.
Momentum Clinical Research AU is a member of the Global Site Holdings Group. Global Site Holdings Pty Limited ACN 668 977 062 trading as Momentum Clinical Research ABN 51 668 977 062 and our related entities (we, us, our), will use the Personal Information you have provided in the above form to review and respond to your enquiry, to contact you about any future trials or studies you may be eligible for, and otherwise in accordance with our Privacy Policy and as required and authorised by law. We may not be able to provide you with a complete response or a response at all to your enquiry if you do not provide the requested information. Our Privacy Policy also contains further information about how we collect, use, store or disclose your Personal Information, how you may seek access and correction of your Personal Information, and how you may make a complaint about a breach of privacy. If you have questions, please contact us at contact@momentumclinicalresearch.com.